{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:42:27Z","timestamp":1768966947362,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01056-4","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:52:13Z","timestamp":1768877533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitis"],"prefix":"10.1007","volume":"15","author":[{"given":"Seina","family":"Iwami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-7314","authenticated-orcid":false,"given":"Masahiro","family":"Eriguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riri","family":"Furuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Samejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","volume":"75","author":"D Geetha","year":"2020","unstructured":"Geetha D, Jefferson JA. Anca-associated vasculitis: core curriculum 2020. Am J Kidney Dis. 2020;75:124\u201337. https:\/\/doi.org\/10.1053\/j.ajkd.2019.04.031.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1056_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai KN, Tang SC, Schena FP, et al. IgA nephropathy. Nat Rev Dis Primers. 2016;2(1):16001. https:\/\/doi.org\/10.1038\/nrdp.2016.1.","journal-title":"Nat Rev Dis Primers"},{"key":"1056_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91:1014\u201321. https:\/\/doi.org\/10.1016\/j.kint.2017.02.003.","journal-title":"Kidney Int"},{"key":"1056_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/art.39614","volume":"68","author":"RL Rhee","year":"2016","unstructured":"Rhee RL, Hogan SL, Poulton CJ, et al. Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated vasculitis with renal disease. Arthritis Rheumatol. 2016;68:1711\u201320. https:\/\/doi.org\/10.1002\/art.39614.","journal-title":"Arthritis Rheumatol"},{"key":"1056_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.26442\/terarkh201890655-58","volume":"90","author":"EM Shchegoleva","year":"2018","unstructured":"Shchegoleva EM, Bulanov NM, Novikov PI, Moiseev SV. Clinical features of kidney involvement in microscopic polyangiitis. Ter Arkh. 2018;90:55\u20138. https:\/\/doi.org\/10.26442\/terarkh201890655-58.","journal-title":"Ter Arkh"},{"key":"1056_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2215\/CJN.06460622","volume":"18","author":"M Casal Moura","year":"2023","unstructured":"Casal Moura M, Specks U, Tehranian S, et al. Maintenance of remission and risk of relapse in myeloperoxidase-positive ANCA-associated vasculitis with kidney involvement. Clin J Am Soc Nephrol. 2023;18:47\u201359. https:\/\/doi.org\/10.2215\/CJN.06460622.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1056_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6690658","volume":"2021","author":"H Hounoki","year":"2021","unstructured":"Hounoki H, Shinoda K, Matsui A, et al. A case of systemic lupus erythematosus and antineutrophil cytoplasmic antibodies-associated vasculitis overlap syndrome. Case Rep Rheumatol. 2021;2021:6690658. https:\/\/doi.org\/10.1155\/2021\/6690658.","journal-title":"Case Rep Rheumatol"},{"key":"1056_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001472","volume":"94","author":"R Zou","year":"2015","unstructured":"Zou R, Liu G, Cui Z, Chen M, Zhao MH. Clinical and immunologic characteristics of patients with ANCA-associated glomerulonephritis combined with membranous nephropathy: a retrospective cohort study in a single Chinese center. Med (Baltimore). 2015;94:e1472. https:\/\/doi.org\/10.1097\/MD.0000000000001472.","journal-title":"Med (Baltimore)"},{"key":"1056_CR9","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2215\/CJN.13591215","volume":"11","author":"M Canney","year":"2016","unstructured":"Canney M, O\u2019Hara PV, McEvoy CM, et al. Spatial and temporal clustering of anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2016;11:1392\u20139. https:\/\/doi.org\/10.2215\/CJN.13591215.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1056_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56030103","volume":"56","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Kaewput W, Boonpheng B, et al. Impact of ANCA-associated vasculitis on outcomes of hospitalizations for goodpasture\u2019s syndrome in the United States: nationwide inpatient sample 2003-2014. Med (Kaunas). 2020;56:103. https:\/\/doi.org\/10.3390\/medicina56030103.","journal-title":"Med (Kaunas)"},{"key":"1056_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1053\/ajkd.2000.17615","volume":"36","author":"M Haas","year":"2000","unstructured":"Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis. 2000;36:709\u201318. https:\/\/doi.org\/10.1053\/ajkd.2000.17615.","journal-title":"Am J Kidney Dis"},{"key":"1056_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1053\/j.ajkd.2009.09.031","volume":"55","author":"C Bantis","year":"2010","unstructured":"Bantis C, Stangou M, Schlaugat C, et al. Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series. Am J Kidney Dis. 2010;55:259\u201368. https:\/\/doi.org\/10.1053\/j.ajkd.2009.09.031.","journal-title":"Am J Kidney Dis"},{"key":"1056_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5414\/CN108571","volume":"84","author":"X Huang","year":"2015","unstructured":"Huang X, Wang Y, Xie L, et al. IgA nephropathy with anti-neutrophil cytoplasmic antibody seropositivity. Clin Nephrol. 2015;84:156\u201364. https:\/\/doi.org\/10.5414\/CN108571.","journal-title":"Clin Nephrol"},{"key":"1056_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/ckj\/sfv078","volume":"8","author":"YZ Yang","year":"2015","unstructured":"Yang YZ, Shi SF, Chen YQ, et al. Clinical features of IgA nephropathy with serum ANCA positivity: a retrospective case-control study. Clin Kidney J. 2015;8:482\u20138. https:\/\/doi.org\/10.1093\/ckj\/sfv078.","journal-title":"Clin Kidney J"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s10067-017-3931-z","volume":"37","author":"L Xie","year":"2018","unstructured":"Xie L, He J, Liu X, et al. Clinical value of systemic symptoms in IgA nephropathy with ANCA positivity. Clin Rheumatol. 2018;37:1953\u201361. https:\/\/doi.org\/10.1007\/s10067-017-3931-z.","journal-title":"Clin Rheumatol"},{"key":"1056_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/J.EJR.2020.06.002","volume":"42","author":"N Chebotareva","year":"2020","unstructured":"Chebotareva N, Kamyshova E, Bulanov N, Lysenko L, Moiseev S. Antineutrophil cytoplasmic autoantibody (ANCA) positive immunoglobulin A (IgA) nephropathy: case reports and review of literature. Egypt Rheumatol. 2020;42:251\u20134. https:\/\/doi.org\/10.1016\/J.EJR.2020.06.002.","journal-title":"Egypt Rheumatol"},{"key":"1056_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.24634","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken). 2021;73:1088\u2013105. https:\/\/doi.org\/10.1002\/acr.24634.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1056_CR18","doi-asserted-by":"publisher","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P, ADVOCATE Study Group. Avacopan for the treatment of ANCA-associated vasculitis. [published Correction appears in N Engl J Med. 2024; 390:388]. N Engl J Med. 2021;384:599\u2013609. https:\/\/doi.org\/10.1056\/NEJMoa2023386","DOI":"10.1056\/NEJMoa2023386"},{"key":"1056_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2215\/CJN.08600718","volume":"14","author":"A Thompson","year":"2019","unstructured":"Thompson A, Carroll K, A Inker L, et al. Proteinuria reduction as a surrogate end point in trials of IgA nephropathy. Clin J Am Soc Nephrol. 2019;14:469\u201381. https:\/\/doi.org\/10.2215\/CJN.08600718.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4S","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1\u2013276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"},{"key":"1056_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s10157-024-02617-0","volume":"29","author":"J Li","year":"2025","unstructured":"Li J, Nie Z, Li G, Bao B. Efficacy and safety of rituximab in primary IgA nephropathy: a retrospective study. Clin Exp Nephrol. 2025;29:616\u201323. https:\/\/doi.org\/10.1007\/s10157-024-02617-0.","journal-title":"Clin Exp Nephrol"},{"key":"1056_CR22","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1681\/ASN.2016060640","volume":"28","author":"RA Lafayette","year":"2017","unstructured":"Lafayette RA, Canetta PA, Rovin BH, et al. A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction. J Am Soc Nephrol. 2017;28:1306\u201313. https:\/\/doi.org\/10.1681\/ASN.2016060640.","journal-title":"J Am Soc Nephrol"},{"key":"1056_CR23","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/ndt\/gfac296","volume":"38","author":"CK Cheung","year":"2023","unstructured":"Cheung CK, Dormer JP, Barratt J. The role of complement in glomerulonephritis-are novel therapies ready for prime time? Nephrol Dial Transpl. 2023;38:1789\u201397. https:\/\/doi.org\/10.1093\/ndt\/gfac296.","journal-title":"Nephrol Dial Transpl"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ckj\/sfab294","volume":"15","author":"A Bruchfeld","year":"2022","unstructured":"Bruchfeld A, Magin H, Nachman P, et al. C5a receptor inhibitor avacopan in immunoglobulin A nephropathy-an open-label pilot study. Clin Kidney J. 2022;15:922\u20138. https:\/\/doi.org\/10.1093\/ckj\/sfab294.","journal-title":"Clin Kidney J"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","volume":"65","author":"M Haas","year":"2004","unstructured":"Haas M, Eustace JA. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004;65:2145\u201352. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00632.x.","journal-title":"Kidney Int"},{"key":"1056_CR26","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1093\/ndt\/gfad082","volume":"38","author":"CJ Willey","year":"2023","unstructured":"Willey CJ, Coppo R, Schaefer F, Mizerska-Wasiak M, Mathur M, Schultz MJ. The incidence and prevalence of IgA nephropathy in Europe. Nephrol Dial Transpl. 2023;38:2340\u20139. https:\/\/doi.org\/10.1093\/ndt\/gfad082.","journal-title":"Nephrol Dial Transpl"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01056-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01056-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:22:38Z","timestamp":1768922558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01056-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01056-4","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. Written informed consent was obtained from the patient prior to the kidney biopsy. The study protocol was approved by the Ethics Committee of Nara Medical University (approval number: 05\u201318).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient for publication of the case details.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"23"}}